摘要
Recently,the team led by Dr.Zhengli Shi from Wuhan Institute of Virology,Chinese Academy of Sciences,and Dr.Peter Daszak from Ecohealth Alliance identified SL-CoVs in Chinese horseshoe bats that were 95%identical to human SARS-CoV and were able to use human angiotensin-converting enzyme 2 (ACE2) receptor for docking and entry.Remarkably,they isolated the first known live bat SL-CoV that replicates in human